Abstract
Background
The relationship between computed tomography (CT)-assessed sarcopenia and colorectal cancer (CRC) prognosis varies in different studies. This systematic review aimed to examine the impact of preoperative CT-assessed sarcopenia on complications and long-term survival in CRC patients.
Methods
The PubMed, Web of Science, Cochrane Library, and Embase databases were searched for relevant literature up to September 10, 2020. Data and characteristics for each study were extracted. Long-term outcomes were assessed using a comprehensive HR with a 95% CI. Complications were assessed using a comprehensive OR with 95% CI. The heterogeneity and publication bias were also investigated, and subgroup and sensitivity analyses were performed.
Results
A total of 19 studies comprising 15,889 patients were included. The comprehensive results demonstrated that sarcopenia is significantly associated with overall survival of CRC patients (HR = 1.40, 95% CI = 1.25–1.58, p < 0.001). Patients with sarcopenia have a higher risk of complications compared to those without sarcopenia. In addition, sarcopenia is strongly associated with poor cancer-specific survival (HR = 1.49, 95% CI = 1.32–1.68, p < 0.001) and disease-free survival (HR = 1.59, 95% CI = 1.32–1.92, p < 0.001) in CRC patients. There is no significant relationship between sarcopenia and recurrence-free survival (HR = 1.32, 95% CI = 0.92–1.89, p = 0.126).
Conclusions
Preoperative CT-assessed sarcopenia can be employed as an effective predictor of complications and long-term prognosis in CRC patients. Standardization of CT-assessed sarcopenia requires comprehensive consideration of race, muscle mass index, body mass index, and gender.
Similar content being viewed by others
Data availability
All datasets presented in this study are included in the article.
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424
Siegel RL, Miller KD, Sauer AG, Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA, Jemal A (2020) Colorectal cancer statistics, 2020. CA Cancer J Clin 70(3):145–164. https://doi.org/10.3322/caac.21601
Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH et al (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66(4):271–289
Yang Z, Zhou X, Ma B, Xing Y (2018) Predictive value of preoperative sarcopenia in patients with gastric cancer: a meta-analysis and systematic review. J Gastrointest Surg 22(11):1890–1902
Bundred J, Kamarajah SK, Roberts KJ (2019) Body composition assessment and sarcopenia in patients with pancreatic cancer: a systematic review and meta-analysis. HPB (Oxford) 21(12):1603–1612
Yang M, Shen Y, Tan L, Li W (2019) Prognostic value of sarcopenia in lung cancer: a systematic review and meta-analysis. Chest 156(1):101–111
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F et al (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People. Age Ageing 39(4):412–423
Paddon-Jones D, Short KR, Campbell WW, Volpi E, Wolfe RR (2008) Role of dietary protein in the sarcopenia of aging. Am J Clin Nutr 87(5):1562s-s1566
Sayer AA, Dennison EM, Syddall HE, Jameson K, Martin HJ, Cooper C (2008) The developmental origins of sarcopenia: using peripheral quantitative computed tomography to assess muscle size in older people. J Gerontol A Biol Sci Med Sci 63(8):835–840
Feliciano EMC, Kroenke CH, Meyerhardt JA, Prado CM, Bradshaw PT, Kwan ML et al (2017) Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results from the C SCANS study. JAMA Oncol 3(12):e172319
Dolan RD, Almasaudi AS, Dieu LB, Horgan PG, McSorley ST, McMillan DC (2019) The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer. J Cachexia Sarcopenia Muscle 10(1):111–122
Xie H, Gong Y, Kuang J, Yan L, Ruan G, Tang S et al (2020) Computed tomography-determined sarcopenia is a useful imaging biomarker for predicting postoperative outcomes in elderly colorectal cancer patients. Cancer Res Treat 52(3):957–972
Wang S, Xie H, Gong Y, Kuang J, Yan L, Ruan G et al (2020) The value of L3 skeletal muscle index in evaluating preoperative nutritional risk and long-term prognosis in colorectal cancer patients. Sci Rep 10(1):8153
van Vugt JLA, Coebergh van den Braak RRJ, Lalmahomed ZS, Vrijland WW, Dekker JWT, Zimmerman DDE et al (2018) Impact of low skeletal muscle mass and density on short and long-term outcome after resection of stage I-III colorectal cancer. Eur J Surg Oncol 44(9):1354–1360
Sun G, Li Y, Peng Y, Lu D, Zhang F, Cui X et al (2018) Can sarcopenia be a predictor of prognosis for patients with non-metastatic colorectal cancer? A systematic review and meta-analysis. Int J Colorectal Dis 33(10):1419–1427
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 372:n71
Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR (2007) Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 8:16
Huang DD, Wang SL, Zhuang CL, Zheng BS, Lu JX, Chen FF et al (2015) Sarcopenia, as defined by low muscle mass, strength and physical performance, predicts complications after surgery for colorectal cancer. Colorectal Dis 17(11):O256–O264
Miyamoto Y, Baba Y, Sakamoto Y, Ohuchi M, Tokunaga R, Kurashige J et al (2015) Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol 22(8):2663–2668
Malietzis G, Currie A, Athanasiou T, Johns N, Anyamene N, Glynne-Jones R et al (2016) Influence of body composition profile on outcomes following colorectal cancer surgery. Br J Surg 103(5):572–580
Caan BJ, Meyerhardt JA, Kroenke CH, Alexeeff S, Xiao J, Weltzien E et al (2017) Explaining the obesity paradox: the association between body composition and colorectal cancer survival (C-SCANS Study). Cancer Epidemiol Biomarkers Prev 26(7):1008–1015
Feliciano EMC, Kroenke CH, Meyerhardt JA, Prado CM, Bradshaw PT, Kwan ML et al (2017) Association of systemic inflammation and sarcopenia with survival in nonmetastatic colorectal cancer: results from the C SCANS study. JAMA Oncol 3(12):e172319
Chen W-Z, Chen X-D, Ma L-L, Zhang F-M, Lin J, Zhuang C-L et al (2018) Impact of visceral obesity and sarcopenia on short-term outcomes after colorectal cancer surgery. Dig Dis Sci 63(6):1620–1630
Nakanishi R, Oki E, Sasaki S, Hirose K, Jogo T, Edahiro K et al (2018) Sarcopenia is an independent predictor of complications after colorectal cancer surgery. Surg Today 48(2):151–157
Sueda T, Takahasi H, Nishimura J, Hata T, Matsuda C, Mizushima T et al (2018) Impact of low muscularity and myosteatosis on long-term outcome after curative colorectal cancer surgery: a propensity score–matched analysis. Dis Colon Rectum 61(3):364–374
van Vugt JL, van den Braak RRC, Lalmahomed ZS, Vrijland WW, Dekker JW, Zimmerman DD et al (2018) Impact of low skeletal muscle mass and density on short and long-term outcome after resection of stage I-III colorectal cancer. Eur J Surg Oncol 44(9):1354–1360
Hopkins JJ, Reif RL, Bigam DL, Baracos VE, Eurich DT, Sawyer MB (2019) The impact of muscle and adipose tissue on long-term survival in patients with stage I to III colorectal cancer. Dis Colon Rectum 62(5):549–560
Yang J, Zhang T, Feng D, Dai X, Lv T, Wang X et al (2019) A new diagnostic index for sarcopenia and its association with short-term postoperative complications in patients undergoing surgery for colorectal cancer. Colorectal Dis 21(5):538–547
Aro R, Mäkäräinen-Uhlbäck E, Ämmälä N, Rautio T, Ohtonen P, Saarnio J, Meriläinen S (2020) The impact of sarcopenia and myosteatosis on postoperative outcomes and 5-year survival in curatively operated colorectal cancer patients – a retrospective register study. Eur J Surg Oncol 46(9):1656–1662. https://doi.org/10.1016/j.ejso.2020.03.206
Chen W, Huang Y, Xu L, Shi M, Chen X, Ye G et al (2020) Effects of sarcopenia, hypoalbuminemia, and laparoscopic surgery on postoperative complications in elderly patients with colorectal cancer: a prospective study. Neoplasma 67(4):922–932
Han JS, Ryu H, Park IJ, Kim KW, Shin Y, Kim SO et al (2020) Association of body composition with long-term survival in non-metastatic rectal cancer patients. Cancer Res Treatment 52(2):563
Lee CS, Won DD, Oh SN, Lee YS, Lee IK, Kim IH, Choi MH, Oh ST (2020) Prognostic role of pre-sarcopenia and body composition with long-term outcomes in obstructive colorectal cancer: a retrospective cohort study. World J Surg Oncol 18(1):230. https://doi.org/10.1186/s12957-020-02006-3
Shirdel M, Andersson F, Myte R, Axelsson J, Rutegård M, Blomqvist L, Riklund K, van Guelpen B, Palmqvist R, Gylling B (2020) Body composition measured by computed tomography is associated with colorectal cancer survival, also in early-stage disease. Acta Oncol 59(7):799–808. https://doi.org/10.1080/0284186X.2020.1744716
Xiao J, Caan BJ, Feliciano EMC, Meyerhardt JA, Peng PD, Baracos VE et al (2020) Association of low muscle mass and low muscle radiodensity with morbidity and mortality for colon cancer surgery. JAMA Surg 155(10):942. https://doi.org/10.1001/jamasurg.2020.2497
Wang S, Xie H, Gong Y, Kuang J, Yan L, Ruan G et al (2020) The value of L3 skeletal muscle index in evaluating preoperative nutritional risk and long-term prognosis in colorectal cancer patients. Sci Rep 10(1):1–11
Bianchini F, Kaaks R, Vainio H (2002) Overweight, obesity, and cancer risk. Lancet Oncol 3(9):565–574
Rosenberg IH (1997) Sarcopenia: origins and clinical relevance. J Nutr 127(5 Suppl):990S–991S. https://doi.org/10.1093/jn/127.5.990S
Xie H, Gong Y, Kuang J, Yan L, Ruan G, Tang S, Gao F, Gan J (2020) Computed tomography–determined sarcopenia is a useful imaging biomarker for predicting postoperative outcomes in elderly colorectal cancer patients. Cancer Res Treatment 52(3):957–972. https://doi.org/10.4143/crt.2019.695
Zhuang Cheng-Le, Huang Dong-Dong, Pang Wen-Yang, Zhou Chong-Jun, Wang Su-Lin, Lou Neng, Ma Liang-Liang, Zhen Yu, Shen Xian (2016) Sarcopenia is an independent predictor of severe postoperative complications and long-term survival after radical gastrectomy for gastric cancer: analysis from a large-scale cohort. Medicine 95(13):e3164. https://doi.org/10.1097/MD.0000000000003164
Simonsen C, Kristensen TS, Sundberg A, Wielsøe S, Christensen J, Hansen CP et al (2021) Assessment of sarcopenia in patients with upper gastrointestinal tumors: prevalence and agreement between computed tomography and dual-energy x-ray absorptiometry. Clin Nutr 40(5):2809–2816
Goodpaster BH, Thaete FL, Kelley DE (2000) Composition of skeletal muscle evaluated with computed tomography. Ann N Y Acad Sci 904(1):18–24
Reisinger KW, van Vugt JL, Tegels JJ, Snijders C, Hulsewé KW, Hoofwijk AG et al (2015) Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Ann Surg 261(2):345–352
Wen M-J, Hsieh C-H, Wu C-Z, Hsiao F-C, Hsia T-L, Hung Y-J et al (2013) The adipokines and inflammatory marker in young type 2 diabetics with metabolic syndrome: a pilot study. Obes Res Clin Pract 7(3):e206–e210
Van Vledder M, Levolger S, Ayez N, Verhoef C, Tran T, Ijzermans J (2012) Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 99(4):550–557
Richards CH, Roxburgh CS, MacMillan MT, Isswiasi S, Robertson EG, Guthrie GK et al (2012) The relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer. PloS one. 7(8):e41883
Alemán MR, Santolaria F, Batista N, Marıa J, González-Reimers E, Milena A et al (2002) Leptin role in advanced lung cancer. A mediator of the acute phase response or a marker of the status of nutrition? Cytokine 19(1):21–6
Stene GB, Helbostad JL, Balstad TR, Riphagen II, Kaasa S, Oldervoll LM (2013) Effect of physical exercise on muscle mass and strength in cancer patients during treatment—a systematic review. Crit Rev Oncol Hematol 88(3):573–593
Strasser B, Steindorf K, Wiskemann J, Ulrich CM (2013) Impact of resistance training in cancer survivors: a meta-analysis. Med Sci Sports Exerc 45(11):2080–2090
Dallmann R, Weyermann P, Anklin C, Boroff M, Bray-French K, Cardel B et al (2011) The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia. J Cachexia Sarcopenia Muscle 2(3):163–174
Berardi E, Annibali D, Cassano M, Crippa S, Sampaolesi M (2014) Molecular and cell-based therapies for muscle degenerations: a road under construction. Front Physiol 5:119
Lau EM, Lynn HS, Woo JW, Kwok TC, Melton LJ 3rd (2005) Prevalence of and risk factors for sarcopenia in elderly Chinese men and women. J Gerontol A Biol Sci Med Sci 60(2):213–216
Author information
Authors and Affiliations
Contributions
J.L.G., S.Y.T., H.L.X., and L.S.W. designed this research; M.X.L., G.H.Y., and S.Y.T. performed the statistical analysis; H.L.X. and L.S.W. performed the data extraction, and drafted and revised the manuscript. All authors reviewed and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethical approval
This article did not contain any studies with human participants or animals performed by any of the authors.
Informed consent
Considering the nature of this study, informed consent was not required.
Conflict of interest
The authors declare no competing interests.
Additional information
Research registration number
The protocol was registered at PROSPERO: CRD42020216306.
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Xie, H., Wei, L., Liu, M. et al. Preoperative computed tomography-assessed sarcopenia as a predictor of complications and long-term prognosis in patients with colorectal cancer: a systematic review and meta-analysis. Langenbecks Arch Surg 406, 1775–1788 (2021). https://doi.org/10.1007/s00423-021-02274-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-021-02274-x